Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 132

1.

Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction.

Nepper-Christensen L, Høfsten DE, Helqvist S, Lassen JF, Tilsted HH, Holmvang L, Pedersen F, Joshi F, Sørensen R, Bang L, Bøtker HE, Terkelsen CJ, Maeng M, Jensen LO, Aarøe J, Kelbæk H, Køber L, Engstrøm T, Lønborg J.

Heart. 2019 Jul 17. pii: heartjnl-2019-314952. doi: 10.1136/heartjnl-2019-314952. [Epub ahead of print]

PMID:
31315939
2.

Unreported exclusion and sampling bias in interpretation of randomized controlled trials in patients with STEMI.

Laursen PN, Holmvang L, Lønborg J, Køber L, Høfsten DE, Helqvist S, Clemmensen P, Kelbæk H, Jørgensen E, Lassen JF, Pedersen F, Høi-Hansen T, Raungaard B, Terkelsen CJ, Jensen LO, Sadjadieh G, Engstrøm T.

Int J Cardiol. 2019 Aug 15;289:1-5. doi: 10.1016/j.ijcard.2019.04.064. Epub 2019 May 1.

PMID:
31078351
3.

Impact of Multiple Myocardial Scars Detected by CMR in Patients Following STEMI.

Ekström K, Nepper-Christensen L, Ahtarovski KA, Kyhl K, Göransson C, Bertelsen L, Ghotbi AA, Kelbæk H, Helqvist S, Høfsten DE, Køber L, Schoos MM, Vejlstrup N, Lønborg J, Engstrøm T.

JACC Cardiovasc Imaging. 2019 Apr 10. pii: S1936-878X(19)30241-4. doi: 10.1016/j.jcmg.2019.01.032. [Epub ahead of print]

PMID:
31005537
4.

Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.

Kyhl K, Ahtarovski KA, Nepper-Christensen L, Ekström K, Ghotbi AA, Schoos M, Göransson C, Bertelsen L, Helqvist S, Holmvang L, Jørgensen E, Pedersen F, Saunamäki K, Clemmensen P, De Backer O, Høfsten DE, Køber L, Kelbæk H, Vejlstrup N, Lønborg J, Engstrøm T.

JACC Cardiovasc Interv. 2019 Apr 22;12(8):721-730. doi: 10.1016/j.jcin.2019.01.248.

PMID:
31000010
5.

Characterisation of lesions undergoing ischaemia-driven revascularisation after complete revascularisation versus culprit lesion only in patients with STEMI and multivessel disease: a DANAMI-3-PRIMULTI substudy.

De Backer O, Lønborg J, Helqvist S, Warnøe J, Kløvgaard L, Holmvang L, Pedersen F, Tilsted HH, Raungaard B, Jørgensen E, Køber L, Høfsten DE, Kelbæk H, Engstrøm T.

EuroIntervention. 2019 Jun 20;15(2):172-179. doi: 10.4244/EIJ-D-18-00766.

6.

Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.

Kofoed KF, Kelbæk H, Hansen PR, Torp-Pedersen C, Høfsten D, Kløvgaard L, Holmvang L, Helqvist S, Jørgensen E, Galatius S, Pedersen F, Bang L, Saunamaki K, Clemmensen P, Linde JJ, Heitmann M, Wendelboe Nielsen O, Raymond IE, Kristiansen OP, Svendsen IH, Bech J, Dominguez Vall-Lamora MH, Kragelund C, Hansen TF, Dahlgaard Hove J, Jørgensen T, Fornitz GG, Steffensen R, Jurlander B, Abdulla J, Lyngbæk S, Elming H, Therkelsen SK, Abildgaard U, Jensen JS, Gislason G, Køber LV, Engstrøm T.

Circulation. 2018 Dec 11;138(24):2741-2750. doi: 10.1161/CIRCULATIONAHA.118.037152. Erratum in: Circulation. 2018 Dec 11;138(24):e750.

PMID:
30565996
7.

Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction.

Nepper-Christensen L, Lønborg J, Høfsten DE, Ahtarovski KA, Bang LE, Helqvist S, Kyhl K, Køber L, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T.

Circ Cardiovasc Interv. 2018 Sep;11(9):e006842. doi: 10.1161/CIRCINTERVENTIONS.118.006842.

PMID:
30354595
8.

Importance of elevated heart rate in the very early phase of ST-segment elevation myocardial infarction: Results from the DANAMI-3 trial.

Nepper-Christensen L, Lønborg J, Ahtarovski KA, Høfsten DE, Kyhl K, Schoos MM, Göransson C, Laursen PN, Sadjadieh G, Ghotbi AA, Bertelsen L, Køber L, Helqvist S, Pedersen F, Jørgensen E, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T.

Eur Heart J Acute Cardiovasc Care. 2019 Jun;8(4):318-328. doi: 10.1177/2048872618795515. Epub 2018 Aug 23.

PMID:
30136597
9.

Bleeding Events After ST-segment Elevation Myocardial Infarction in Patients Randomized to an All-comer Clinical Trial Compared With Unselected Patients.

Sadjadieh G, Engstrøm T, Høfsten DE, Helqvist S, Køber L, Pedersen F, Laursen PN, Andersson HB, Nepper-Christensen L, Clemmensen P, Sørensen R, Jørgensen E, Saunamäki K, Tilsted HH, Kelbæk H, Holmvang L.

Am J Cardiol. 2018 Oct 15;122(8):1287-1296. doi: 10.1016/j.amjcard.2018.07.008. Epub 2018 Jul 19.

PMID:
30115422
10.

Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study.

Laursen PN, Holmvang L, Lønborg J, Køber L, Høfsten DE, Helqvist S, Clemmensen P, Kelbæk H, Jørgensen E, Lassen JF, Pedersen F, Høi-Hansen T, Therkelsen CJ, Tilsted HH, Jensen LO, Nepper-Christensen L, Sadjadieh G, Engstrøm T.

Am Heart J. 2018 Oct;204:128-138. doi: 10.1016/j.ahj.2018.05.018. Epub 2018 Aug 10.

PMID:
30103092
11.

Assessment of the myocardial area at risk: comparing T2-weighted cardiovascular magnetic resonance imaging with contrast-enhanced cine (CE-SSFP) imaging-a DANAMI3 substudy.

Göransson C, Ahtarovski KA, Kyhl K, Lønborg J, Nepper-Christensen L, Bertelsen L, Ghotbi AA, Schoos MM, Køber L, Høfsten D, Helqvist S, Kelbæk H, Engstrøm T, Vejlstrup N.

Eur Heart J Cardiovasc Imaging. 2019 Mar 1;20(3):361-366. doi: 10.1093/ehjci/jey106.

PMID:
30085055
12.

Can copeptin and troponin T ratio predict final infarct size and myocardial salvage index in patients with ST-elevation myocardial infarction: A sub-study of the DANAMI-3 trial.

Árnadóttir Á, Schoos M, Lønborg J, Ahtarovski K, Kelbæk H, Helqvist S, Høfsten D, Clemmensen P, Engstrøm T, Nepper-Christensen L, Vejlstrup N, Køber L, Iversen K.

Clin Biochem. 2018 Sep;59:37-42. doi: 10.1016/j.clinbiochem.2018.06.012. Epub 2018 Jun 20.

PMID:
29932892
13.

MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy.

Falkentoft AC, Rørth R, Iversen K, Høfsten DE, Kelbæk H, Holmvang L, Frydland M, Schoos MM, Helqvist S, Axelsson A, Clemmensen P, Jørgensen E, Saunamäki K, Tilsted HH, Pedersen F, Torp-Pedersen C, Kofoed KF, Goetze JP, Engstrøm T, Køber L.

J Am Heart Assoc. 2018 May 18;7(11). pii: e008123. doi: 10.1161/JAHA.117.008123.

14.

Subtraction CT angiography improves evaluation of significant coronary artery disease in patients with severe calcifications or stents-the C-Sub 320 multicenter trial.

Fuchs A, Kühl JT, Chen MY, Viladés Medel D, Alomar X, Shanbhag SM, Helqvist S, Kofoed KF.

Eur Radiol. 2018 Oct;28(10):4077-4085. doi: 10.1007/s00330-018-5418-y. Epub 2018 Apr 25.

PMID:
29696430
15.

Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial.

Engstrøm T, Nepper-Christensen L, Helqvist S, Kløvgaard L, Holmvang L, Jørgensen E, Pedersen F, Saunamaki K, Tilsted HH, Steensberg A, Fabricius S, Mouritzen U, Vejlstrup N, Ahtarovski KA, Göransson C, Bertelsen L, Kyhl K, Olivecrona G, Kelbæk H, Lassen JF, Køber L, Lønborg J.

Heart. 2018 Oct;104(19):1593-1599. doi: 10.1136/heartjnl-2017-312774. Epub 2018 Mar 30.

PMID:
29602883
16.

Relation of Bleeding Events to Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated by Percutaneous Coronary Intervention (a DANAMI-3 Substudy).

Sadjadieh G, Engstrøm T, Helqvist S, Høfsten DE, Køber L, Pedersen F, Laursen PN, Nepper-Christensen L, Clemmensen P, Møller-Helgestad OK, Sørensen R, Ravkilde J, Terkelsen CJ, Jørgensen E, Saunamäki K, Tilsted HH, Kelbæk H, Holmvang L.

Am J Cardiol. 2018 Apr 1;121(7):781-788. doi: 10.1016/j.amjcard.2017.12.019. Epub 2018 Jan 12.

PMID:
29402421
17.

Adipose-Derived Stromal Cells for Treatment of Patients with Chronic Ischemic Heart Disease (MyStromalCell Trial): A Randomized Placebo-Controlled Study.

Qayyum AA, Mathiasen AB, Mygind ND, Kühl JT, Jørgensen E, Helqvist S, Elberg JJ, Kofoed KF, Vejlstrup NG, Fischer-Nielsen A, Haack-Sørensen M, Ekblond A, Kastrup J.

Stem Cells Int. 2017;2017:5237063. doi: 10.1155/2017/5237063. Epub 2017 Dec 3.

18.

Impact of diagnostic ECG-to-wire delay in STEMI patients treated with primary PCI: a DANAMI-3 substudy.

Nepper-Christensen L, Lønborg J, Høfsten DE, Ahtarovski KA, Kyhl K, Göransson C, Køber L, Helqvist S, Pedersen F, Kelbæk H, Vejlstrup N, Holmvang L, Engstrøm T.

EuroIntervention. 2018 Aug 20;14(6):700-707. doi: 10.4244/EIJ-D-17-00857.

19.

Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease.

Andersson HB, Pedersen F, Engstrøm T, Helqvist S, Jensen MK, Jørgensen E, Kelbæk H, Räder SBEW, Saunamäki K, Bates E, Grande P, Holmvang L, Clemmensen P.

Eur Heart J. 2018 Jan 7;39(2):102-110. doi: 10.1093/eurheartj/ehx491.

PMID:
29029035
20.

Cryopreserved Off-the-Shelf Allogeneic Adipose-Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure-A Safety Study.

Kastrup J, Haack-Sørensen M, Juhl M, Harary Søndergaard R, Follin B, Drozd Lund L, Mønsted Johansen E, Ali Qayyum A, Bruun Mathiasen A, Jørgensen E, Helqvist S, Jørgen Elberg J, Bruunsgaard H, Ekblond A.

Stem Cells Transl Med. 2017 Nov;6(11):1963-1971. doi: 10.1002/sctm.17-0040. Epub 2017 Sep 7.

21.

Diagnostic Accuracy of Coronary CT Angiography for the Evaluation of Bioresorbable Vascular Scaffolds.

Collet C, Chevalier B, Cequier A, Fajadet J, Dominici M, Helqvist S, Van Boven AJ, Dudek D, McClean D, Almeida M, Piek JJ, Tenekecioglu E, Bartorelli A, Windecker S, Serruys PW, Onuma Y.

JACC Cardiovasc Imaging. 2018 May;11(5):722-732. doi: 10.1016/j.jcmg.2017.04.013. Epub 2017 Jul 19.

PMID:
28734923
22.

Myocardial Damage in Patients With Deferred Stenting After STEMI: A DANAMI-3-DEFER Substudy.

Lønborg J, Engstrøm T, Ahtarovski KA, Nepper-Christensen L, Helqvist S, Vejlstrup N, Kyhl K, Schoos MM, Ghotbi A, Göransson C, Bertelsen L, Holmvang L, Pedersen F, Jørgensen E, Saunamäki K, Clemmensen P, De Backer O, Kløvgaard L, Høfsten DE, Køber L, Kelbæk H; DANAMI-3 Investigators.

J Am Coll Cardiol. 2017 Jun 13;69(23):2794-2804. doi: 10.1016/j.jacc.2017.03.601.

23.

Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).

Lønborg J, Engstrøm T, Kelbæk H, Helqvist S, Kløvgaard L, Holmvang L, Pedersen F, Jørgensen E, Saunamäki K, Clemmensen P, De Backer O, Ravkilde J, Tilsted HH, Villadsen AB, Aarøe J, Jensen SE, Raungaard B, Køber L, Høfsten DE; DANAMI 3-PRIMULTI Investigators.

Circ Cardiovasc Interv. 2017 Apr;10(4). pii: e004460. doi: 10.1161/CIRCINTERVENTIONS.116.004460.

PMID:
28404623
24.

Association Between Early Q Waves and Reperfusion Success in Patients With ST-Segment-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: A Cardiac Magnetic Resonance Imaging Study.

Topal DG, Lønborg J, Ahtarovski KA, Nepper-Christensen L, Helqvist S, Holmvang L, Pedersen F, Clemmensen P, Saünamaki K, Jørgensen E, Kyhl K, Ghotbi A, Schoos MM, Göransson C, Bertelsen L, Høfsten D, Køber L, Kelbæk H, Vejlstrup N, Engstrøm T.

Circ Cardiovasc Interv. 2017 Mar;10(3). pii: e004467. doi: 10.1161/CIRCINTERVENTIONS.116.004467.

PMID:
28264870
25.

Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction: A Randomized Clinical Trial.

Engstrøm T, Kelbæk H, Helqvist S, Høfsten DE, Kløvgaard L, Clemmensen P, Holmvang L, Jørgensen E, Pedersen F, Saunamaki K, Ravkilde J, Tilsted HH, Villadsen A, Aarøe J, Jensen SE, Raungaard B, Bøtker HE, Terkelsen CJ, Maeng M, Kaltoft A, Krusell LR, Jensen LO, Veien KT, Kofoed KF, Torp-Pedersen C, Kyhl K, Nepper-Christensen L, Treiman M, Vejlstrup N, Ahtarovski K, Lønborg J, Køber L; Third Danish Study of Optimal Acute Treatment of Patients With ST Elevation Myocardial Infarction–Ischemic Postconditioning (DANAMI-3–iPOST) Investigators.

JAMA Cardiol. 2017 May 1;2(5):490-497. doi: 10.1001/jamacardio.2017.0022.

26.

Left Ventricular Hypertrophy Is Associated With Increased Infarct Size and Decreased Myocardial Salvage in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

Nepper-Christensen L, Lønborg J, Ahtarovski KA, Høfsten DE, Kyhl K, Ghotbi AA, Schoos MM, Göransson C, Bertelsen L, Køber L, Helqvist S, Pedersen F, Saünamaki K, Jørgensen E, Kelbæk H, Holmvang L, Vejlstrup N, Engstrøm T.

J Am Heart Assoc. 2017 Jan 9;6(1). pii: e004823. doi: 10.1161/JAHA.116.004823.

27.

Pseudomonas aeruginosa Microcolonies in Coronary Thrombi from Patients with ST-Segment Elevation Myocardial Infarction.

Hansen GM, Belstrøm D, Nilsson M, Helqvist S, Nielsen CH, Holmstrup P, Tolker-Nielsen T, Givskov M, Hansen PR.

PLoS One. 2016 Dec 28;11(12):e0168771. doi: 10.1371/journal.pone.0168771. eCollection 2016.

28.

Bleeding episodes in "complete, staged" versus "culprit only" revascularisation in patients with multivessel disease and ST-segment elevation myocardial infarction: a DANAMI-3-PRIMULTI substudy.

Sadjadieh G, Engstrøm T, Helqvist S, Høfsten DE, Køber L, Pedersen F, Clemmensen P, Jørgensen E, Saunamäki K, Tilsted HH, Kelbæk H, Holmvang L.

EuroIntervention. 2016 Nov 20;12(10):1231-1238. doi: 10.4244/EIJV12I10A203.

29.

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.

Serruys PW, Chevalier B, Sotomi Y, Cequier A, Carrié D, Piek JJ, Van Boven AJ, Dominici M, Dudek D, McClean D, Helqvist S, Haude M, Reith S, de Sousa Almeida M, Campo G, Iñiguez A, Sabaté M, Windecker S, Onuma Y.

Lancet. 2016 Nov 19;388(10059):2479-2491. doi: 10.1016/S0140-6736(16)32050-5. Epub 2016 Oct 30. Erratum in: Lancet. 2017 Feb 25;389(10071):804.

PMID:
27806897
30.

Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial.

Chevalier B, Onuma Y, van Boven AJ, Piek JJ, Sabaté M, Helqvist S, Baumbach A, Smits PC, Kumar R, Wasungu L, Serruys PW.

EuroIntervention. 2016 Oct 20;12(9):1102-1107. doi: 10.4244/EIJY16M08_01.

31.

Deferred stenting in acute ST elevation myocardial infarction - Authors' reply.

Kelbæk H, Høfsten DE, Engstrøm T, Helqvist S, Køber L.

Lancet. 2016 Oct 1;388(10052):1371-1372. doi: 10.1016/S0140-6736(16)31466-0. No abstract available.

PMID:
27707487
32.

A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction.

Kyhl K, Lønborg J, Vejlstrup N, Kelbæk H, Helqvist S, Holmvang L, Jørgensen E, Saunamäki K, Bøtker HE, Clemmensen P, Køber L, Treiman M, Engstrøm T.

EuroIntervention. 2016 Jul 20;12(4):449-55. doi: 10.4244/EIJV12I4A78.

33.

Invasive angiography and revascularization in patients with stable angina following prior coronary artery bypass grafting: Results from the East Denmark heart registry.

Joshi FR, Biasco L, Pedersen F, Holmvang L, Helqvist S, Tilsted HH, Abildgaard U, Kelbaek H, Lassen JF, Jørgensen E, De Backer O, Engstrøm T.

Catheter Cardiovasc Interv. 2017 Feb 15;89(3):341-349. doi: 10.1002/ccd.26598. Epub 2016 May 24.

PMID:
27219901
34.

Comparison of Outcome of Patients With ST-Segment Elevation Myocardial Infarction and Complete Versus Incomplete ST-Resolution Before Primary Percutaneous Coronary Intervention.

Lønborg J, Kelbæk H, Holmvang L, Helqvist S, Vejlstrup N, Jørgensen E, Saunamäki K, Dridi NP, Kløvgaard L, Kaltoft A, Bøtker HE, Lassen JF, Clemmensen P, Terkelsen CJ, Engstrøm T.

Am J Cardiol. 2016 Jun 1;117(11):1735-40. doi: 10.1016/j.amjcard.2016.03.009. Epub 2016 Mar 18.

PMID:
27062938
35.

Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial.

Kelbæk H, Høfsten DE, Køber L, Helqvist S, Kløvgaard L, Holmvang L, Jørgensen E, Pedersen F, Saunamäki K, De Backer O, Bang LE, Kofoed KF, Lønborg J, Ahtarovski K, Vejlstrup N, Bøtker HE, Terkelsen CJ, Christiansen EH, Ravkilde J, Tilsted HH, Villadsen AB, Aarøe J, Jensen SE, Raungaard B, Jensen LO, Clemmensen P, Grande P, Madsen JK, Torp-Pedersen C, Engstrøm T.

Lancet. 2016 May 28;387(10034):2199-206. doi: 10.1016/S0140-6736(16)30072-1. Epub 2016 Apr 3.

PMID:
27053444
36.

The incidence and relevance of site-reported vs. patient-reported angina: insights from the ABSORB II randomized trial comparing Absorb everolimus-eluting bioresorbable scaffold with XIENCE everolimus-eluting metallic stent.

Grundeken MJ, White RM, Hernandez JB, Dudek D, Cequier A, Haude M, van Boven AJ, Piek JJ, Helqvist S, Sabate M, Baumbach A, Suwannasom P, Ishibashi Y, Staehr P, Veldhof S, Cheong WF, de Winter RJ, Garcia-Garcia HM, Wykrzykowska JJ, Onuma Y, Serruys PW, Chevalier B.

Eur Heart J Qual Care Clin Outcomes. 2016 Apr 1;2(2):108-116. doi: 10.1093/ehjqcco/qcv022.

PMID:
29474621
37.

Long-term outcome of FFR-guided PCI for stable coronary artery disease in daily clinical practice: a propensity score-matched landmark analysis.

De Backer O, Biasco L, Lønborg J, Pedersen F, Holmvang L, Kelbaek H, Arnous S, Saunamäki K, Helqvist S, Kastrup J, Jørgensen E, Engstrøm T.

EuroIntervention. 2016 Feb;11(11):e1257-66. doi: 10.4244/EIJV11I11A247.

38.

Absence of Bacteria on Coronary Angioplasty Balloons from Unselected Patients: Results with Use of a High Sensitivity Polymerase Chain Reaction Assay.

Hansen GM, Nilsson M, Nielsen CH, Holmstrup P, Helqvist S, Tolker-Nielsen T, Givskov M, Hansen PR.

PLoS One. 2015 Dec 22;10(12):e0145657. doi: 10.1371/journal.pone.0145657. eCollection 2015.

39.

Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.

Engstrøm T, Kelbæk H, Helqvist S, Høfsten DE, Kløvgaard L, Holmvang L, Jørgensen E, Pedersen F, Saunamäki K, Clemmensen P, De Backer O, Ravkilde J, Tilsted HH, Villadsen AB, Aarøe J, Jensen SE, Raungaard B, Køber L; DANAMI-3—PRIMULTI Investigators.

Lancet. 2015 Aug 15;386(9994):665-71.

PMID:
26347918
40.

Incidence and Potential Mechanism(s) of Post-Procedural Rise of Cardiac Biomarker in Patients With Coronary Artery Narrowing After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold or Everolimus-Eluting Metallic Stent.

Ishibashi Y, Muramatsu T, Nakatani S, Sotomi Y, Suwannasom P, Grundeken MJ, Cho YK, Garcia-Garcia HM, van Boven AJ, Piek JJ, Sabaté M, Helqvist S, Baumbach A, McClean D, de Sousa Almeida M, Wasungu L, Miquel-Hebert K, Dudek D, Chevalier B, Onuma Y, Serruys PW.

JACC Cardiovasc Interv. 2015 Jul;8(8):1053-1063. doi: 10.1016/j.jcin.2015.06.001.

41.

Feasibility of coronary calcium and stent image subtraction using 320-detector row CT angiography.

Fuchs A, Kühl JT, Chen MY, Helqvist S, Razeto M, Arakita K, Steveson C, Arai AE, Kofoed KF.

J Cardiovasc Comput Tomogr. 2015 Sep-Oct;9(5):393-8. doi: 10.1016/j.jcct.2015.03.016. Epub 2015 Apr 16.

42.

Predictors and prognostic value of left atrial remodelling after acute myocardial infarction.

Kyhl K, Vejlstrup N, Lønborg J, Treiman M, Ahtarovski KA, Helqvist S, Kelbæk H, Holmvang L, Jørgensen E, Saunamäki K, Søholm H, Andersen MJ, Møller JE, Clemmensen P, Engstrøm T.

Open Heart. 2015 Jun 8;2(1):e000223. doi: 10.1136/openhrt-2014-000223. eCollection 2015.

43.

Prehospital administration of P2Y12 inhibitors and early coronary reperfusion in primary PCI: an observational comparative study.

De Backer O, Ratcovich H, Biasco L, Pedersen F, Helqvist S, Saunamäki K, Tilsted HH, Clemmensen P, Olivecrona G, Kelbaek H, Jørgensen E, Engstrøm T, Holmvang L.

Thromb Haemost. 2015 Aug 31;114(3):623-31. doi: 10.1160/TH15-01-0026. Epub 2015 May 21.

PMID:
25994355
44.

The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: Ischemic postconditioning or deferred stent implantation versus conventional primary angioplasty and complete revascularization versus treatment of culprit lesion only: Rationale and design of the DANAMI 3 trial program.

Høfsten DE, Kelbæk H, Helqvist S, Kløvgaard L, Holmvang L, Clemmensen P, Torp-Pedersen C, Tilsted HH, Bøtker HE, Jensen LO, Køber L, Engstrøm T; DANAMI 3 Investigators.

Am Heart J. 2015 May;169(5):613-21. doi: 10.1016/j.ahj.2015.02.004. Epub 2015 Feb 14.

PMID:
25965708
45.

Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial).

Mathiasen AB, Qayyum AA, Jørgensen E, Helqvist S, Fischer-Nielsen A, Kofoed KF, Haack-Sørensen M, Ekblond A, Kastrup J.

Eur Heart J. 2015 Jul 14;36(27):1744-53. doi: 10.1093/eurheartj/ehv136. Epub 2015 Apr 29.

PMID:
25926562
46.

Angiographic characteristics of intermediate stenosis of the left anterior descending artery for determination of lesion significance as identified by fractional flow reserve.

Biasco L, Pedersen F, Lønborg J, Holmvang L, Helqvist S, Saunamäki K, Kelbaek H, Clemmensen P, Olivecrona GK, Jørgensen E, Engstrøm T, De Backer O.

Am J Cardiol. 2015 Jun 1;115(11):1475-80. doi: 10.1016/j.amjcard.2015.02.047. Epub 2015 Mar 11.

PMID:
25857401
47.

Short- and long-term cause of death in patients treated with primary PCI for STEMI.

Pedersen F, Butrymovich V, Kelbæk H, Wachtell K, Helqvist S, Kastrup J, Holmvang L, Clemmensen P, Engstrøm T, Grande P, Saunamäki K, Jørgensen E.

J Am Coll Cardiol. 2014 Nov 18-25;64(20):2101-8. doi: 10.1016/j.jacc.2014.08.037. Epub 2014 Nov 10.

48.

Optimal catchment area and primary PCI centre volume revisited: a single-centre experience in transition from high-volume centre to "mega centre" for patients with ST-segment elevation myocardial infarction.

Schoos MM, Pedersen F, Holmvang L, Engstrøm T, Saunamaki K, Helqvist S, Kastrup J, Mehran R, Dangas G, Jørgensen E, Kelbæk H, Clemmensen P.

EuroIntervention. 2015 Sep;11(5):503-10. doi: 10.4244/EIJY14M11_07.

49.

Tailored antiplatelet therapy to improve prognosis in patients exhibiting clopidogrel low-response prior to percutaneous coronary intervention for stable angina or non-ST elevation acute coronary syndrome.

Paarup Dridi N, Johansson PI, Lønborg JT, Clemmensen P, Radu MD, Qayyum A, Pedersen F, Kollslid R, Helqvist S, Saunamäki K, Kelbæk H, Jørgensen E, Engstrøm T, Holmvang L.

Platelets. 2015;26(6):521-9. doi: 10.3109/09537104.2014.948837. Epub 2014 Aug 28.

PMID:
25166751
50.

ST peak during percutaneous coronary intervention serves as an early prognostic predictor in patients with ST-segment elevation myocardial.

Lønborg J, Kelbæk H, Engstrøm T, Helqvist S, Kløvgaard L, Holmvang L, Vejlstrup N, Jørgensen E, Saunamäki K, Dridi NP, Kaltoft A, Bøtker HE, Clemmensen P, Terkelsen CJ.

EuroIntervention. 2014 Aug;10(4):466-74. doi: 10.4244/EIJV10I4A80.

Supplemental Content

Loading ...
Support Center